RNA NASDAQ
Atrium Therapeutics, Inc.
1W: -1.7%
1M: -4.5%
3M: -82.1%
YTD: -81.9%
1Y: -56.9%
3Y: +15.9%
5Y: -33.5%
$13.09
+0.05 (+0.38%)
Weekly Expected Move ±5.8%
$12
$12
$13
$14
$15
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$37M
Revenue
+312.4% YoY
$-396M
Net Income
-7.4% YoY
$-416M
Free Cash Flow
-14.0% YoY
99.2%
Gross Margin
-88.0%
Op. Margin
-84.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-48.6%
ROA-43.0%
ROIC569.0%
Valuation
P/E-3.5
P/B1.0
EV/EBITDA0.1
Leverage
Debt/Equity0.02
Current Ratio6.53
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-1.81
Beneish M5.26